Streetbeat News

Analyst Ratings

MYNZ

In the last quarter, Mainz Biomed (NASDAQ:MYNZ) received 5 analyst ratings, with 2 being bullish and 3 somewhat bullish. The company has an average 12-month price target of $8.6, which has increased by 1.18% over the past month.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 4:00 pm

WDAY

Over the past 3 months, 30 analysts have published their opinion on Workday (NASDAQ:WDAY) stock. The company has an average price target of $259.77, which has increased by 7.49% from the previous average price target of $241.66. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 4:00 pm

SIBN

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on SI-BONE (NASDAQ:SIBN) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:59 pm

RCEL

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on AVITA Medical (NASDAQ:RCEL) and maintained a $26 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:52 pm

PRE

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Prenetics Global (NASDAQ:PRE) and maintained a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:50 pm

PACB

Cantor Fitzgerald analyst Ross Osborn has reiterated a Neutral rating on Pacific Biosciences (NASDAQ:PACB) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:49 pm

NYXH

Cantor Fitzgerald analyst Steven Halper has reiterated an Overweight rating on Nyxoah (NASDAQ:NYXH) and maintained a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:48 pm

NNOX

Cantor Fitzgerald analyst Steven Halper has reiterated an Overweight rating on Nano X Imaging (NASDAQ:NNOX) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:47 pm

MYNZ

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Mainz Biomed (NASDAQ:MYNZ) and maintained a $9 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 3:46 pm

GWW

W.W. Grainger Inc.'s (NYSE:GWW) share price increased by 0.42% in the current market session to $692.79. Despite a 3.48% fall over the past month, the stock has risen by 40.29% over the past year. The company's P/E ratio of 19.89 is higher than the industry average of 16.39, suggesting that the stock may be overvalued.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 3:46 pm